Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-008826
Filing Date
2017-03-29
Accepted
2017-03-29 17:00:29
Documents
1
Period of Report
2017-03-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1547
  Complete submission text file 0000899243-17-008826.txt   3088
Mailing Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850
Business Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Issuer) CIK: 0001590877 (see all company filings)

EIN.: 471851754 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850
Business Address
Danos Olivier (Reporting) CIK: 0001701180 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37553 | Film No.: 17722850